This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-preview: Archive
Granite Ridge Resources, Inc. (GRNT) Q2 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Granite Ridge Resources, Inc. (GRNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GRNTNegative Net Change CIVINegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
JFrog Ltd. (FROG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
JFrog (FROG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FROGNegative Net Change FSLYNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Golden Entertainment (GDEN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Golden Entertainment (GDEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GDENNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GILDPositive Net Change RXRXNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GMEDPositive Net Change STEPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Eton Pharmaceuticals (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ETONNegative Net Change CERTNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Evergy Inc (EVRG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Evergy (EVRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EVRGPositive Net Change PNWPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Expedia (EXPE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Expedia (EXPE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EXPENegative Net Change WNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Flutter Entertainment (FLUT) Q2 Earnings Expected to Decline
by Zacks Equity Research
Flutter (FLUT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FLUTNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Fox Factory Holding (FOXF) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Fox Factory Holding (FOXF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FOXFNegative Net Change LCIDNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Datadog (DDOG) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Datadog (DDOG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DDOGNegative Net Change DBDNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Krispy Kreme (DNUT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Krispy Kreme (DNUT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DNUTNegative Net Change TDUPPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DOCSNegative Net Change INSPPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Epam (EPAM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Epam (EPAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EPAMNegative Net Change DTNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
COLLPositive Net Change RIGLPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q2 Earnings Expected to Decline
by Zacks Equity Research
CRINETICS PHARM (CRNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CRNXNegative Net Change ESPRNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Crocs (CROX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Crocs (CROX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CROXNegative Net Change RVLVNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Countdown to Advanced Micro (AMD) Q2 Earnings: Wall Street Forecasts for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Advanced Micro (AMD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
AMDNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Chevron (CVX) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Chevron (CVX) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CVXNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unveiling Duke Energy (DUK) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Duke Energy (DUK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
DUKPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Oneok (OKE) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Evaluate the expected performance of Oneok (OKE) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
OKENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Marriott (MAR) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Marriott (MAR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
MARNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Stay Ahead of the Game With Leidos (LDOS) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Leidos (LDOS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
LDOSNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Curious about Cummins (CMI) Q2 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Cummins (CMI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
CMINegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unveiling Marathon Petroleum (MPC) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Marathon Petroleum (MPC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
MPCNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview